BRIEF-Syros announces preclinical data on SY-1425
* Syros presents data at EHA supporting potential of SY-1425, its first-in-class selective RARα agonist, in genomically defined AML and MDS patients
April 6 Visa Inc:
* Visa Inc says Visa checkout reaches 20 million enrolled consumers
* Visa Inc says Samsung pay agrees to integrate with Visa checkout's open platform Source text for Eikon: Further company coverage:
June 23 A handful of drugmakers are taking their first steps toward developing marijuana-based painkillers, alternatives to opioids that have led to widespread abuse and caused the U.S. health regulator to ask for a withdrawal of a popular drug this month.